Progressive Vestibular Schwannoma following Subtotal or Near-Total Resection: Dose-Escalated versus Standard-Dose Salvage Stereotactic Radiosurgery

Abstract

Objective Local failure of incompletely resected vestibular schwannoma (VS) following salvage stereotactic radiosurgery (SRS) using standard doses of 12 to 13 Gy is common. We hypothesized that dose-escalated SRS, corrected for biologically effective dose, would have superior local control of high-grade VS progressing after subtotal or near-total resection compared with standard-dose SRS.

Design Retrospective cohort study.

Setting Tertiary academic referral center.

Participants Adult patients treated with linear accelerator-based SRS for progressive VS following subtotal or near-total resection.

Main Outcome Measures Dose-escalated SRS was defined by a biologically effective dose exceeding a single-fraction 13-Gy regimen. Study outcomes were local control and neurologic sequelae of SRS. Binary logistic regression was used to evaluate predictors of study outcomes.

Results A total of 18 patients with progressive disease following subtotal (71%) and near-total (39%) resection of Koos grade IV disease (94%) were enrolled. Of the 18 patients, 7 were treated with dose-escalated SRS and 11 with standard-dose SRS. Over a median follow-up of 32 months after SRS, local control was 100% in the dose-escalated cohort and 91% in the standard-dose cohort (p = 0.95). Neurologic sequelae occurred in 28% of patients, including 60% of dose-escalated cohort and 40% of the standard-dose cohort (p = 0.12), although permanent neurologic sequelae were low at 6%.

Conclusions Dose-escalated SRS has similar local control of recurrent VS following progression after subtotal or near-total resection and does not appear to have higher neurologic sequalae. Larger studies are needed.

Keywords

vestibular schwannoma - stereotactic radiosurgery - outcomes - radiation dose - progression - cohort - salvage - acoustic neuroma

^* These authors contributed equally.

Publikationsverlauf

Eingereicht: 11. September 2019

Angenommen: 19. März 2020

Artikel online veröffentlicht:
26. Mai 2020

• References

• 1 Marinelli JP, Grossardt BR, Lohse CM, Carlson ML. Prevalence of sporadic vestibular schwannoma: reconciling temporal bone, radiologic, and population-based studies. Otol Neurotol 2019; 40 (03) 384-390
• 2 Harati A, Scheufler KM, Schultheiss R. et al. Clinical features, microsurgical treatment, and outcome of vestibular schwannoma with brainstem compression. Surg Neurol Int 2017; 8: 45
• 3 Jain VK, Mehrotra N, Sahu RN, Behari S, Banerji D, Chhabra DK. Surgery of vestibular schwannomas: an institutional experience. Neurol India 2005; 53 (01) 41-45
• 4 Koos WT, Day JD, Matula C, Levy DI. Neurotopographic considerations in the microsurgical treatment of small acoustic neurinomas. J Neurosurg 1998; 88 (03) 506-512
• 5 Nagano O, Higuchi Y, Serizawa T. et al. Transient expansion of vestibular schwannoma following stereotactic radiosurgery. J Neurosurg 2008; 109 (05) 811-816
• 6 Khattab MH, Newman NB, Wharton DM. et al. Longitudinal radiographic outcomes of vestibular schwannoma in single and fractionated stereotactic radiosurgery: a retrospective cohort study. J Neurol Surg Part B Skull Base 2020; 81 (03) 308-316
• 7 van de Langenberg R, Hanssens PEJ, Verheul JB. et al. Management of large vestibular schwannoma. Part II. Primary Gamma Knife surgery: radiological and clinical aspects. J Neurosurg 2011; 115 (05) 885-893
• 8 Samii M, Gerganov VM, Samii A. Functional outcome after complete surgical removal of giant vestibular schwannomas. J Neurosurg 2010; 112 (04) 860-867
• 9 Frischer JM, Gruber E, Schöffmann V. et al. Long-term outcome after Gamma Knife radiosurgery for acoustic neuroma of all Koos grades: a single-center study. J Neurosurg 2018. Doi: 10.3171/2017.8.jns171281
• 10 Gurgel RK, Dogru S, Amdur RL, Monfared A. Facial nerve outcomes after surgery for large vestibular schwannomas: do surgical approach and extent of resection matter?. Neurosurg Focus 2012; 33 (03) E16
• 11 Monfared A, Corrales CE, Theodosopoulos PV. et al. Facial nerve outcome and tumor control rate as a function of degree of resection in treatment of large acoustic neuromas: preliminary report of the Acoustic Neuroma Subtotal Resection Study (ANSRS). Neurosurgery 2016; 79 (02) 194-203
• 12 Hadjipanayis CG, Carlson ML, Link MJ. et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines on surgical resection for the treatment of patients with vestibular schwannomas. Neurosurgery 2018; 82 (02) E40-E43
• 13 van de Langenberg R, Hanssens PEJ, van Overbeeke JJ. et al. Management of large vestibular schwannoma. Part I. Planned subtotal resection followed by Gamma Knife surgery: radiological and clinical aspects. J Neurosurg 2011; 115 (05) 875-884
• 14 Pan HC, Sheehan J, Sheu ML, Chiu WT, Yang DY. Intracapsular decompression or radical resection followed by Gamma Knife surgery for patients harboring a large vestibular schwannoma. J Neurosurg 2012; 117 (Suppl): 69-77
• 15 Iwai Y, Ishibashi K, Watanabe Y, Uemura G, Yamanaka K. Functional preservation after planned partial resection followed by Gamma Knife Radiosurgery for large vestibular schwannomas. World Neurosurg 2015; 84 (02) 292-300
• 16 Copeland WR, Carlson ML, Neff BA, Driscoll CLW, Link MJ. Management of residual tumor after limited subtotal resection of large vestibular schwannomas: lessons learned and rationale for specialized care. World Neurosurg 2017; 105: 737-744
• 17 Pollock BE, Lunsford LD, Flickinger JC, Clyde BL, Kondziolka D. Vestibular schwannoma management. Part I. Failed microsurgery and the role of delayed stereotactic radiosurgery. J Neurosurg 1998; 89 (06) 944-948
• 18 Pollock BE, Link MJ. Vestibular schwannoma radiosurgery after previous surgical resection or stereotactic radiosurgery. Prog Neurol Surg 2008; 21: 163-168
• 19 Liu C, Lin Q, Yun Z. Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity. Radiat Res 2015; 183 (05) 487-496
• 20 Govaert KM, Emmink BL, Nijkamp MW. et al. Hypoxia after liver surgery imposes an aggressive cancer stem cell phenotype on residual tumor cells. Ann Surg 2014; 259 (04) 750-759
• 21 Govaert KM, Jongen JMJ, Kranenburg O, Borel Rinkes IHM. Surgery-induced tumor growth in (metastatic) colorectal cancer. Surg Oncol 2017; 26 (04) 535-543
• 22 Fowler JF. 21 years of biologically effective dose. Br J Radiol 2010; 83 (991) 554-568
• 23 Niranjan A, Flickinger JC. Radiobiology, principle and technique of radiosurgery. Prog Neurol Surg 2008; 21: 32-42
• 24 Kondziolka D, Shin SM, Brunswick A, Kim I, Silverman JS. The biology of radiosurgery and its clinical applications for brain tumors. Neuro-oncol 2015; 17 (01) 29-44
• 25 Hall EJ, Brenner DJ. The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys 1993; 25 (02) 381-385
• 26 Carlson ML, Vivas EX, McCracken DJ. et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines on hearing preservation outcomes in patients with sporadic vestibular schwannomas. Neurosurgery 2018; 82 (02) E35-E39
• 27 Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC. Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 1998; 339 (20) 1426-1433
• 28 Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1948; 1 (01) 3-29
• 29 Jacob JT, Carlson ML, Driscoll CL, Link MJ. Volumetric analysis of tumor control following subtotal and near-total resection of vestibular schwannoma. Laryngoscope 2016; 126 (08) 1877-1882
• 30 Breshears JD, Morshed RA, Molinaro AM, McDermott MW, Cheung SW, Theodosopoulos PV. Residual tumor volume and location predict progression after primary subtotal resection of sporadic vestibular schwannomas: a retrospective volumetric study. Neurosurgery 2020; 86 (03) 410-416
• 31 Brokinkel B, Sauerland C, Holling M. et al. Gamma Knife radiosurgery following subtotal resection of vestibular schwannoma. J Clin Neurosci 2014; 21 (12) 2077-2082
• 32 Unger F, Walch C, Papaefthymiou G, Feichtinger K, Trummer M, Pendl G. Radiosurgery of residual and recurrent vestibular schwannomas. Acta Neurochir (Wien) 2002; 144 (07) 671-676
• 33 Zumofen DW, Guffi T, Epple C. et al. Intended near-total removal of Koos grade IV vestibular schwannomas: reconsidering the treatment paradigm. Neurosurgery 2018; 82 (02) 202-210
• 34 Collen C, Ampe B, Gevaert T. et al. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Int J Radiat Oncol Biol Phys 2011; 81 (04) e503-e509
• 35 Chung WY, Pan DHC, Lee CC. et al. Large vestibular schwannomas treated by Gamma Knife surgery: long-term outcomes. J Neurosurg 2010; 113 (Suppl): 112-121
• 36 Sughrue ME, Yang I, Han SJ. et al. Non-audiofacial morbidity after Gamma Knife surgery for vestibular schwannoma. Neurosurg Focus 2009; 27 (06) E4
• 37 Yang I, Sughrue ME, Han SJ. et al. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol 2009; 93 (01) 41-48
• 38 Badakhshi H, Graf R, Böhmer D, Synowitz M, Wiener E, Budach V. Results for local control and functional outcome after linac-based image-guided stereotactic radiosurgery in 190 patients with vestibular schwannoma. J Radiat Res (Tokyo) 2014; 55 (02) 288-292
• 39 Flickinger JC, Kondziolka D, Lunsford LD. Dose and diameter relationships for facial, trigeminal, and acoustic neuropathies following acoustic neuroma radiosurgery. Radiother Oncol 1996; 41 (03) 215-219
• 40 Khattab MH, Sherry AD, Whitaker R. et al. A retrospective cohort study of longitudinal audiologic assessment in single and fractionated stereotactic radiosurgery for vestibular schwannoma. Neurosurgery 2019; 85 (06) E1078-E1083
• 41 Udawatta M, Kwan I, Preet K. et al. Hearing preservation for vestibular schwannomas treated with stereotactic radiosurgery or fractionated stereotactic radiotherapy. World Neurosurg 2019; 129: e303-e310
• 42 Chan M, Rogers CL, Anderson B, Khuntia D. Benign brain tumors: meningiomas and vestibular schwannomas. In: Gunderson L, Tepper J, Bogart J. eds. Clinical Radiation Oncology. 4th ed. Philadelphia, PA: Elsevier; 2016: 483-501
• 43 Andrews DW, Suarez O, Goldman HW. et al. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 2001; 50 (05) 1265-1278
• 44 Combs SE, Volk S, Schulz-Ertner D, Huber PE, Thilmann C, Debus J. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Int J Radiat Oncol Biol Phys 2005; 63 (01) 75-81
• 45 Park HR, Park KW, Lee JM. et al. Frameless fractionated gamma knife radiosurgery with ICON™ for large metastatic brain tumors. J Korean Med Sci 2019; 34 (08) e57
• 46 McTyre E, Helis CA, Farris M. et al. Emerging indications for fractionated Gamma knife radiosurgery. Neurosurgery 2017; 80 (02) 210-216
• 47 Yomo S, Hayashi M, Nicholson C. A prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors. J Neurooncol 2012; 109 (01) 159-165
• 48 Vulpe H, Save A, Xu Y. et al. Frameless stereotactic radiosurgery on the Gamma Knife Icon: early experience from 100 patients. Neurosurgery 2020; 86 (04) 509-516